Observational study of Baroezet tablet for high cholesterol
Part of Hormones & metabolism clinical trials.
This study looks at how well and how safely a new tablet (Baroezet) works in Korean patients with dyslipidemia. It is an observational study, which means you will take the tablet as prescribed by your doctor, and researchers will collect data about your health without changing your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have been diagnosed with dyslipidemia (unhealthy levels of fats in your blood).
- Your doctor has decided that treatment with Baroezet Tablet is right for you.
- You are willing to provide written informed consent to participate.
- You do not have an active liver disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol
This study tests a new medicine called HS-10582 to see if it is safe and how well it works in people with mildly high LDL cholesterol (the 'bad' cholesterol). It may help lower cholesterol levels and could be a future treatment option.
This study watches how well a combination cholesterol medication (pitavastatin and ezetimibe) works in people who have high cholesterol and metabolic syndrome (a cluster of health issues including high blood pressure, blood sugar, and cholesterol). You'll be monitored over time to see if the medication helps and is safe for you.
This trial tests whether ezetimibe, a cholesterol-lowering drug, changes the bacteria in your gut. It may help people with heart disease or high cholesterol who are already on a statin.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.